Enabling Global Partners to Evaluate and Deploy Chinese Biopharma Innovation
Bridging multidisciplinary capabilities across biology, medicine, chemistry, and engineering with disciplined equipment delivery and commercial execution.
A Long-Term Industrial Partner for Cross-Border Biopharma Execution
China has established deep technical capabilities across life science R&D, biomanufacturing, and automated process equipment. Shanghai BA Technology Co., Ltd. (BA Tech) serves as a trusted translational bridge connecting these capabilities with global industrial partners.
Core Advantages | Why BA Tech
Cross-Cultural BD & Multi-Jurisdiction Alignment
Fluent in Chinese, English, Japanese, and Russian business workflows, we collaborate with qualified local regulatory specialists to support registration and compliance across target markets while mitigating cross-border execution risk.
Technical Depth & End-to-End Integration
Our core team combines Tsinghua academic roots with seasoned international industry leadership across biologics, automated bioprocessing, and cGMP compliance, guiding technical evaluation, partner matching, deal structuring, and execution.
Execution Beyond Deal Signing
We go beyond licensing introductions and one-off procurement, coordinating critical equipment integration alongside steady-state reagent and consumable supply to sustain long-term commercial value.
Long-Term Industrial Partnership
Rather than acting as a one-off transactional intermediary, we serve as a strategic execution partner helping international clients deploy validated Chinese life science technologies and equipment to achieve clinical and commercial milestones.
Moving from single transactions to deep, verifiable project delivery.
Integrating China's Biopharma R&D and Advanced Manufacturing Network
Connecting China's universities, research institutes, and biopharma and life science supply network to align with overseas partners' R&D, product sourcing, and manufacturing requirements, driving cross-border technology collaboration and commercialization.
Biopharma & Synthetic Biology Innovation
Focusing on differentiated antibody and cell & gene therapy (CGT) pipelines alongside frontier synthetic biology and biomanufacturing technologies, connecting vetted R&D assets to advance technology sourcing, international licensing, and cross-border collaboration.
Biopharma & Life Science Supply Chain
Integrating bioprocessing equipment, laboratory instrumentation, in vitro diagnostics (IVD), and critical reagents and consumables across R&D, process development, and manufacturing, providing overseas partners with cost-effective, dependable supply and technical support.
Academic & Translational Research Network
Leveraging our core team's deep academic ties, we connect China's leading universities, research institutes, and state key laboratories in biopharmaceuticals and bioengineering with global partners to drive translational research, technology transfer, joint R&D, and commercialization.
Start a Cross-Border
Biopharma & Biotech Collaboration
Whether you are exploring cross-border pipeline licensing, custom automated bioprocess equipment, or supply chain integration in China, we welcome your inquiry. A managing partner for the relevant practice will respond within 3 business days.